NESTMEDIC S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.81 PLN | -5.81% |
|
-0.25% | -41.73% |
| Feb. 09 | Nestmedic S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Feb. 09 | Nestmedic S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 655K 163K | Sales 2022 | 1.87M 464K | Capitalization | 42.28M 10.51M |
|---|---|---|---|---|---|
| Net income 2021 | -3M -746K | Net income 2022 | -4M -994K | EV / Sales 2021 | 38.4 x |
| Net Debt 2021 | 2.93M 729K | Net Debt 2022 | 4.53M 1.13M | EV / Sales 2022 | 25.1 x |
| P/E ratio 2021 |
-5.31
x | P/E ratio 2022 |
-7.48
x | Employees | 9 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.23% |
More Fundamentals
* Assessed data
More news
| 1 day | -5.81% | ||
| 1 week | -0.25% | ||
| Current month | +1.89% | ||
| 1 month | +1.89% | ||
| 3 months | -34.68% | ||
| 6 months | -41.30% | ||
| Current year | -41.73% |
1 week
0.79
0.90
1 month
0.720.93
Current year
0.721.44
1 year
0.722.22
3 years
0.722.90
5 years
0.703.00
10 years
0.7017.99
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Administrative Officer | - | - | |
| Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Karol Hop
BRD | Director/Board Member | 35 | - |
| Corporate Officer/Principal | - | - | |
Kamil Gorzelnik
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-28 | 0.81 | -5.81% | 23 740 |
| 24-04-26 | 0.86 | 0.00% | 2,731 |
| 24-04-25 | 0.86 | -4.02% | 3,021 |
| 24-04-24 | 0.896 | +0.67% | 20 |
| 24-04-23 | 0.89 | 0.00% | 737 |
End-of-day quote Warsaw S.E., April 28, 2024
More quotes
Nestmedic SA is a Poland-based company engaged in the manufacture of medical diagnostic equipment. The Company focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures motherâs pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
| 1st Jan change | Capi. | |
|---|---|---|
| -41.73% | 5.84M | |
| -12.42% | 19.08B | |
| -46.59% | 2.65B | |
| +17.50% | 1.87B | |
| -0.58% | 1.61B | |
| +25.36% | 1.21B | |
| -8.67% | 1.02B | |
| -21.91% | 905M | |
| -4.42% | 716M | |
| -17.51% | 682M |
- Stock Market
- Equities
- NST Stock
